Inhibition of vesicular glutamate storage and exocytotic release by Rose Bengal
dc.contributor.author | Ogita, Kiyokazu | en_US |
dc.contributor.author | Hirata, Koji | en_US |
dc.contributor.author | Bole, David G. | en_US |
dc.contributor.author | Yoshida, Sumiko | en_US |
dc.contributor.author | Tamura, Yutaka | en_US |
dc.contributor.author | Leckenby, Anne Marie | en_US |
dc.contributor.author | Ueda, Tetsufumi | en_US |
dc.date.accessioned | 2010-04-01T15:15:16Z | |
dc.date.available | 2010-04-01T15:15:16Z | |
dc.date.issued | 2001-04-01 | en_US |
dc.identifier.citation | Ogita, Kiyokazu; Hirata, Koji; Bole, David G.; Yoshida, Sumiko; Tamura, Yutaka; Leckenby, Anne Marie; Ueda, Tetsufumi (2001). "Inhibition of vesicular glutamate storage and exocytotic release by Rose Bengal." Journal of Neurochemistry 77(1): 34-42. <http://hdl.handle.net/2027.42/65725> | en_US |
dc.identifier.issn | 0022-3042 | en_US |
dc.identifier.issn | 1471-4159 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/65725 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=11279259&dopt=citation | en_US |
dc.format.extent | 785332 bytes | |
dc.format.extent | 3110 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Science Ltd | en_US |
dc.rights | 2001, International Society for Neurochemistry, Journal of N | en_US |
dc.subject.other | Glutamate | en_US |
dc.subject.other | Inhibitor | en_US |
dc.subject.other | Release | en_US |
dc.subject.other | Rose Bengal | en_US |
dc.subject.other | Vesicular Uptake | en_US |
dc.title | Inhibition of vesicular glutamate storage and exocytotic release by Rose Bengal | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | † Psychiatry, Medical School, The University of Michigan, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationother | * Mental Health Research Institute, Departments of | en_US |
dc.contributor.affiliationother | † Pharmacology and | en_US |
dc.identifier.pmid | 11279259 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/65725/1/j.1471-4159.2001.00200.x.pdf | |
dc.identifier.doi | 10.1046/j.1471-4159.2001.00200.x | en_US |
dc.identifier.source | Journal of Neurochemistry | en_US |
dc.identifier.citedreference | Bartlett R. D., Esslinger C. S., Thompson C. M., Bridges R. J. ( 1998 ) Substituted quinolines as inhibitors of l-glutamate transport into synaptic vesicles. Neuropharmacology 37, 839 – 846. | en_US |
dc.identifier.citedreference | Bradford H. F. ( 1995 ) Glutamate, GABA and epilepsy. Prog. Neurobiol. 47, 477 – 511. | en_US |
dc.identifier.citedreference | Bunney B. G., Bunney W. E. Jr, Carlsson A. ( 1995 ) Schizophrenia and glutamate, in Psychopharmacology: The Fourth Generation of Progress ( Bloom F. E. and Kupfer D. J., eds), pp. 1205 – 1214. Raven Press, New York. | en_US |
dc.identifier.citedreference | Burger P. M., Mehl E., Cameron P. L., Maycox P. R., Baumert M., Lottspeich F., De Camilli P., Jahn R. ( 1989 ) Synaptic vesicles immuno-isolated from rat cerebral cortex contain high levels of glutamate. Neuron 3, 715 – 720. | en_US |
dc.identifier.citedreference | Carlson M. D., Kish P. E., Ueda T. ( 1989 ) Glutamate uptake into synaptic vesicles: competitive inhibition by bromocriptine. J. Neurochem. 53, 1889 – 1894. | en_US |
dc.identifier.citedreference | Carrigan C. N., Esslinger C. S., Bartlett R. D., Bridges R. J., Thompson C. M. ( 1999 ) Quinoline-2,4-dicarboxylic acids: synthesis and evaluation as inhibitors of the glutamate vesicular transport system. Bioorg. Med. Chem. Lett. 9, 2607 – 2712. | en_US |
dc.identifier.citedreference | Chapman A. G. ( 1998 ) Glutamate receptors in epilepsy. Prog. Brain Res. 116, 371 – 383. | en_US |
dc.identifier.citedreference | Choi D. W. ( 1988 ) Glutamate neurotoxicity and disease of the nervous system. Neuron 1, 623 – 634. | en_US |
dc.identifier.citedreference | Cidon S. & Sihra T. S. ( 1989 ) Characterization of a H + -ATPase in rat brain synaptic vesicles. J. Biol. Chem. 264, 8281 – 8288. | en_US |
dc.identifier.citedreference | Collingridge G. L. & Singer W. ( 1990 ) Excitatory amino acid receptors and synaptic plasticity. Trends. Pharmacol. Sci. 11, 290 – 296. | en_US |
dc.identifier.citedreference | Cotman C. W., Monaghan D. T., Ganong A. H. ( 1988 ) Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity. Annu. Rev. Neurosci. 11, 61 – 80. | en_US |
dc.identifier.citedreference | Coyle J. T. ( 1996 ) The glutamatergic dysfunction hypothesis for schizophrenia. Harvard Rev. Psychiat. 3, 241 – 253. | en_US |
dc.identifier.citedreference | Feasey K. L., Lynch M. A., Bliss T. V. P. ( 1986 ) Long-term potentiation is associated with an increase in calcium-dependent potassium-stimulated release of [ 14 C]glutamate from hippocampus slices: an ex vivo study in the rat. Brain Res. 364, 39 – 44. | en_US |
dc.identifier.citedreference | Fonnum F. ( 1984 ) Glutamate: a neurotransmitter in mammalian brain. J. Neurochem. 42, 1 – 11. | en_US |
dc.identifier.citedreference | Fykse E. M., Christensen H., Fonnum F. ( 1989 ) Comparison of the properties of γ-aminobutyric acid and l-glutamate uptake into synaptic vesicles isolated from rat brain. J. Neurochem. 52, 946 – 951. | en_US |
dc.identifier.citedreference | Fykse E. M., Iversen E. G., Fonnum F. ( 1992 ) Inhibition of l-glutamate uptake into synaptic vesicles. Neurosci. Lett. 135, 125 – 128. | en_US |
dc.identifier.citedreference | Javitt D. C. & Zukin S. R. ( 1991 ) Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiat. 148, 1301 – 1308. | en_US |
dc.identifier.citedreference | Kish P. E. & Ueda T. ( 1989 ) Glutamate accumulation into synaptic vesicles. Methods Enzymol. 174, 9 – 25. | en_US |
dc.identifier.citedreference | Kish P. E. & Ueda T. ( 1991 ) Calcium-dependent release of accumulated glutamate from synaptic vesicles within permeabilized nerve terminals. Neurosci. Lett. 122, 179 – 182. | en_US |
dc.identifier.citedreference | Krueger B. K., Forn J., Greengard P. ( 1977 ) Depolarization-induced phosphorylation of specific proteins, mediated by calcium ion influx, in rat brain synaptosomes. J. Biol. Chem. 252, 2764 – 2773. | en_US |
dc.identifier.citedreference | Lanzetta P. A., Alvarez L. J., Reinach P. S., Candia O. A. ( 1979 ) An improved assay for nanomole amounts of inorganic phosphate. Anal. Biochem. 100, 95 – 97. | en_US |
dc.identifier.citedreference | Lipton S. A. & Rosenberg P. A. ( 1994 ) Mechanisms of disease: excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330, 613 – 622. | en_US |
dc.identifier.citedreference | McMahon H. T. & Nicholls D. G. ( 1991 ) The bioenergetics of neurotransmitter release. Biochim. Biophys. Acta 1059, 243 – 264. | en_US |
dc.identifier.citedreference | Maycox P. R., Deckwerth T., Hell J. W., Jahn R. ( 1988 ) Glutamate uptake by brain synaptic vesicles. J. Biol. Chem. 263, 15423 – 15428. | en_US |
dc.identifier.citedreference | Maycox P. R., Hell J. W., Jahn R. ( 1990 ) Amino acid neurotransmission: spotlight on synaptic vesicles. Trends Neurosci. 13, 83 – 87. | en_US |
dc.identifier.citedreference | Mehta P. P., Battenberg E., Wilson M. C. ( 1996 ) SNAP-25 and synaptotagmin involvement in the final Ca( 2+ )-dependent triggering of neurotransmitter exocytosis. Proc. Natl Acad. Sci. USA 93, 10471 – 10476. | en_US |
dc.identifier.citedreference | Meldrum B. ( 1985 ) Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters. Clin. Sci. 68, 113 – 122. | en_US |
dc.identifier.citedreference | Moriyama Y., Amakatsu K., Yamada H., Park M.-Y., Futai M. ( 1991 ) Inhibition of neurotransmitter and hormone transport into secretory vesicles by 2-(4-phenylpiperidino) cyclohexanol and 2-bromo-α-ergocryptine; both compounds act as uncouplers and dissipate the electrochemical gradient of protons. Arch. Biochem. Biophys. 290, 233 – 238. | en_US |
dc.identifier.citedreference | Naito S. & Ueda T. ( 1983 ) Adenosine triphosphate-dependent uptake of glutamate into synaptic vesicles. J. Biol. Chem. 258, 696 – 699. | en_US |
dc.identifier.citedreference | Naito S. & Ueda T. ( 1985 ) Characterization of glutamate uptake into synaptic vesicles. J. Neurochem. 44, 99 – 109. | en_US |
dc.identifier.citedreference | Nicholls D. G. ( 1989 ) Release of glutamate, aspartate, and γ-aminobutyric acid from isolated nerve terminals. J. Neurochem. 52, 331 – 341. | en_US |
dc.identifier.citedreference | Nicholls D. G. & Sihra T. S. ( 1986 ) Synaptosomes possess an exocytotic pool of glutamate. Nature 321, 772 – 773. | en_US |
dc.identifier.citedreference | Olney J. W. & Farber N. B. ( 1995 ) Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiat. 52, 998 – 1007. | en_US |
dc.identifier.citedreference | Özkan E. D. & Ueda T. ( 1998 ) Glutamate transport and storage in synaptic vesicles. Jpn. J. Pharmacol. 77, 1 – 10. | en_US |
dc.identifier.citedreference | Özkan E. D., Lee F. S., Ueda T. ( 1997 ) A protein factor that inhibits ATP-dependent glutamate and γ-aminobutyric acid accumulation into synaptic vesicles: purification and initial characterization. Proc. Natl Acad. Sci. USA 94, 4137 – 4142. | en_US |
dc.identifier.citedreference | Roseth S., Fykse E. M., Fonnum F. ( 1995 ) Uptake of l-glutamate into rat brain synaptic vesicles: effect of inhibitors that bind specifically to the glutamate transporter. J. Neurochem. 65, 96 – 103. | en_US |
dc.identifier.citedreference | Roseth S., Fykse E. M., Fonnum F. ( 1998 ) Uptake of l-glutamate into synaptic vesicles: competitive inhibition by dyes with biphenyl and amino- and sulphonic acid-substituted naphthyl groups. Biochem. Pharmacol. 56, 1243 – 1249. | en_US |
dc.identifier.citedreference | Storm-Mathisen J., Leknes A. K., Bore A. T., Vaaland J. L., Edminson P., Haug F.-M. S., Ottersen O. P. ( 1983 ) First visualization of glutamate and GABA in neurons by immunocytochemistry. Nature 301, 517 – 520. | en_US |
dc.identifier.citedreference | Tabb J. S. & Ueda T. ( 1991 ) Phylogenetic studies on the synaptic vesicle glutamate transport system. J. Neurosci. Sci. 11, 1822 – 1828. | en_US |
dc.identifier.citedreference | Tabb J. S., Kish P. E., Van Dyke R., Ueda T. ( 1992 ) Glutamate transport into synaptic vesicles. Roles of membrane potential, pH gradient, and intravesicular pH. J. Biol. Chem. 267, 15412 – 15418. | en_US |
dc.identifier.citedreference | Ueda T. ( 1986 ) Glutamate transport in the synaptic vesicle, in Excitatory Amino Acids ( Roberts P. J., Storm-Mathisen J. and Bradford H. F., eds), pp. 173 – 195. Macmillan, London. | en_US |
dc.identifier.citedreference | Watkins J. C., Krogsgaard-Larsen P., Honore T. ( 1990 ) Structure−activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. Trends Pharmacol. Sci. 11, 25 – 33. | en_US |
dc.identifier.citedreference | Winter H. C. & Ueda T. ( 1993 ) Glutamate uptake system in the presynaptic vesicle: glutamic acid analogs as inhibitors and alternate substrates. Neurochem. Res. 18, 79 – 85. | en_US |
dc.identifier.citedreference | Wolosker H., de Souza D. O., de Meis L. ( 1996 ) Regulation of glutamate transport into synaptic vesicles by chloride and proton gradient. J. Biol. Chem. 271, 11726 – 11731. | en_US |
dc.identifier.citedreference | Yoneda Y. & Ogita K. ( 1989 ) Microbial methodological artifacts in [ 3 H] glutamate receptor binding assays. Anal. Biochem. 177, 250 – 255. | en_US |
dc.identifier.citedreference | Zorumski C. F. & Olney J. W. ( 1993 ) Excitotoxic neuronal damage and neuropsychiatric disorders. Pharmac. Ther. 59, 145 – 162. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.